Drug-coated balloon in peripheral artery disease

Area of Science:

• Vascular Surgery
• Interventional Cardiology
• Endovascular Interventions

Background:

• Peripheral artery disease (PAD) is common and often debilitating, affecting lower extremities.
• While revascularization improves function, traditional surgical methods are being supplemented by endovascular techniques.
• Endovascular strategies face challenges like restenosis and limited long-term patency, especially in complex PAD cases.

Purpose of the Study:

• To review the scientific evidence supporting the use of drug-coated balloons (DCB) in endovascular interventions for lower extremity PAD.
• To evaluate DCB as an alternative to traditional endovascular methods for improving patency rates.

Main Methods:

• Review of existing scientific literature and clinical studies on drug-coated balloons for PAD.
• Analysis of data regarding efficacy, restenosis rates, and patency compared to other endovascular modalities.

Main Results:

• Drug-coated balloons (DCB) are increasingly used for endovascular treatment of lower extremity PAD.
• DCB offer advantages such as ease of use and the 'leave nothing behind' principle.
• Evidence supports DCB's potential to improve patency rates in PAD interventions.

Conclusions:

• Drug-coated balloons (DCB) represent a significant advancement in endovascular therapy for lower extremity PAD.
• Further research and long-term data are crucial to fully establish the role of DCB in PAD management.